AK2
AK2 (adenylate kinase 2) is a mitochondrial enzyme that catalyses the reversible transfer of the terminal phosphate group between ATP and AMP. It sits in the mitochondrial intermembrane space and helps maintain cellular energy homeostasis and adenine nucleotide balance. Browse Assay Genie's current range of AK2 research reagents below, or read on for the biology behind the target.
AK2 catalyses the reversible transfer of the terminal phosphate group between ATP and AMP. Through this activity it plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. Its adenylate kinase activity is critical for regulation of the phosphate utilisation and AMP de novo biosynthesis pathways, and it plays a key role in haematopoiesis.
Adenylate kinases regulate the adenine nucleotide composition within a cell by moving phosphate groups among adenine nucleotides. Three isozymes, 1, 2 and 3, have been identified in vertebrates, and the AK2 gene encodes isozyme 2. Expression of these isozymes is tissue-specific and developmentally regulated. AK2 belongs to the adenylate kinase family, AK2 subfamily, and is localised in the mitochondrial intermembrane space, where it may also play a role in apoptosis. Alternate splicing of the gene results in multiple transcript variants, and pseudogenes are found on chromosomes 1 and 2.
Mutations in the AK2 gene are the cause of reticular dysgenesis, which fits with the enzyme's reported role in haematopoiesis. The protein is classified by HGNC in the adenylate kinases gene group, alongside the other family members such as AK1 and AK3. Researchers studying mitochondrial nucleotide metabolism, energy balance and apoptosis often examine AK2 protein levels and AK2 gene expression, with orthologues present in mouse and rat (both Ak2).
AK2 interconverts ATP and AMP and contributes to cellular energy homeostasis, making it a relevant target for studies of adenine nucleotide balance.
Its activity is critical for regulating phosphate utilisation and the AMP de novo biosynthesis pathways.
AK2 plays a key role in haematopoiesis, and mutations in its gene cause reticular dysgenesis.
AK2 is found in the mitochondrial intermembrane space and may play a role in apoptosis.
AK2 catalyses the reversible transfer of the terminal phosphate group between ATP and AMP. This supports cellular energy homeostasis and adenine nucleotide metabolism, and regulates phosphate utilisation and AMP de novo biosynthesis. It also plays a key role in haematopoiesis.
AK2 is localised in the mitochondrial intermembrane space. It is isozyme 2 of the three adenylate kinase isozymes (1, 2 and 3) identified in vertebrates, whose expression is tissue-specific and developmentally regulated. Alternate splicing produces multiple transcript variants.
Mutations in the AK2 gene cause reticular dysgenesis. Orthologues exist in mouse and rat, both named Ak2, so rodent models are commonly used. Check the datasheet of any product for its validated reactivity.
Other adenylate kinases and related AK-prefixed targets, including kinases and anchoring proteins, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P54819; product specifications from Assay Genie datasheets.